WorldPingSTAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news…
Brief by WorldPing · Original reporting by STAT
WorldPing


